awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35231826-7AECE1F6-A752-477D-B8A8-14401CEE8D8F
Q35231826-7AECE1F6-A752-477D-B8A8-14401CEE8D8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-7AECE1F6-A752-477D-B8A8-14401CEE8D8F
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
P2860
Q35231826-7AECE1F6-A752-477D-B8A8-14401CEE8D8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-7AECE1F6-A752-477D-B8A8-14401CEE8D8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966528fce6da87a67c64b3b0add2cb5df3955829
P2860
Silybin and silymarin--new and emerging applications in medicine.